Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression - PubMed (original) (raw)
Comparative Study
. 2001 Jun;158(6):899-905.
doi: 10.1176/appi.ajp.158.6.899.
Affiliations
- PMID: 11384897
- DOI: 10.1176/appi.ajp.158.6.899
Comparative Study
Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression
S H Kennedy et al. Am J Psychiatry. 2001 Jun.
Abstract
Objective: Depression is commonly associated with frontal hypometabolic activity accompanied by hypermetabolism in certain limbic regions. It is unclear whether successful antidepressant treatments reverse these abnormalities or create new resting levels of metabolism. The aim of the present study was to assess the effects of successful paroxetine treatment on regional glucose metabolism in patients with major depression.
Method: Positron emission tomography with [(18)F]fluorodeoxyglucose was performed on 13 male patients before and after 6 weeks of paroxetine therapy. Resting state scans were also acquired under similar conditions in 24 healthy male subjects for comparison.
Results: After successful paroxetine therapy, increased glucose metabolism occurred in dorsolateral, ventrolateral, and medial aspects of the prefrontal cortex (left greater than right), parietal cortex, and dorsal anterior cingulate. Areas of decreased metabolism were noted in both anterior and posterior insular regions (left) as well as right hippocampal and parahippocampal regions. In comparison to metabolism levels in a group of healthy volunteers, the increase in prefrontal metabolic activity represented a normalization of previously reduced metabolic activity, whereas the reduction in pregenual anterior cingulate activity represented a decrease from previously elevated metabolic levels.
Conclusions: These results provide further support for a dysfunction in cortical-limbic circuitry in depression, which is at least partly reversed after successful paroxetine treatment.
Similar articles
- Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings.
Brody AL, Saxena S, Stoessel P, Gillies LA, Fairbanks LA, Alborzian S, Phelps ME, Huang SC, Wu HM, Ho ML, Ho MK, Au SC, Maidment K, Baxter LR Jr. Brody AL, et al. Arch Gen Psychiatry. 2001 Jul;58(7):631-40. doi: 10.1001/archpsyc.58.7.631. Arch Gen Psychiatry. 2001. PMID: 11448368 Clinical Trial. - Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression.
Saxena S, Brody AL, Ho ML, Zohrabi N, Maidment KM, Baxter LR Jr. Saxena S, et al. Am J Psychiatry. 2003 Mar;160(3):522-32. doi: 10.1176/appi.ajp.160.3.522. Am J Psychiatry. 2003. PMID: 12611834 - Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression.
Smith GS, Reynolds CF 3rd, Pollock B, Derbyshire S, Nofzinger E, Dew MA, Houck PR, Milko D, Meltzer CC, Kupfer DJ. Smith GS, et al. Am J Psychiatry. 1999 May;156(5):683-9. doi: 10.1176/ajp.156.5.683. Am J Psychiatry. 1999. PMID: 10327899 Clinical Trial. - PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review.
Videbech P. Videbech P. Acta Psychiatr Scand. 2000 Jan;101(1):11-20. doi: 10.1034/j.1600-0447.2000.101001011.x. Acta Psychiatr Scand. 2000. PMID: 10674946 Review. - The prefrontal cortex influence over subcortical and limbic regions governs antidepressant response by N=H/(M+R).
Salerian AJ, Altar CA. Salerian AJ, et al. Psychiatry Res. 2012 Oct 30;204(1):1-12. doi: 10.1016/j.pscychresns.2012.04.019. Epub 2012 Sep 28. Psychiatry Res. 2012. PMID: 23022274 Review.
Cited by
- Brain activity in adolescent major depressive disorder before and after fluoxetine treatment.
Tao R, Calley CS, Hart J, Mayes TL, Nakonezny PA, Lu H, Kennard BD, Tamminga CA, Emslie GJ. Tao R, et al. Am J Psychiatry. 2012 Apr;169(4):381-8. doi: 10.1176/appi.ajp.2011.11040615. Am J Psychiatry. 2012. PMID: 22267183 Free PMC article. Clinical Trial. - Cerebrospinal fluid space alterations in melancholic depression.
Via E, Cardoner N, Pujol J, Martínez-Zalacaín I, Hernández-Ribas R, Urretavizacaya M, López-Solà M, Deus J, Menchón JM, Soriano-Mas C. Via E, et al. PLoS One. 2012;7(6):e38299. doi: 10.1371/journal.pone.0038299. Epub 2012 Jun 28. PLoS One. 2012. PMID: 22761673 Free PMC article. - Abnormal Default System Functioning in Depression: Implications for Emotion Regulation.
Messina I, Bianco F, Cusinato M, Calvo V, Sambin M. Messina I, et al. Front Psychol. 2016 Jun 10;7:858. doi: 10.3389/fpsyg.2016.00858. eCollection 2016. Front Psychol. 2016. PMID: 27375536 Free PMC article. Review. - Ketamine and Imipramine Reverse Transcriptional Signatures of Susceptibility and Induce Resilience-Specific Gene Expression Profiles.
Bagot RC, Cates HM, Purushothaman I, Vialou V, Heller EA, Yieh L, LaBonté B, Peña CJ, Shen L, Wittenberg GM, Nestler EJ. Bagot RC, et al. Biol Psychiatry. 2017 Feb 15;81(4):285-295. doi: 10.1016/j.biopsych.2016.06.012. Epub 2016 Jun 18. Biol Psychiatry. 2017. PMID: 27569543 Free PMC article. - Increased cortical-limbic anatomical network connectivity in major depression revealed by diffusion tensor imaging.
Fang P, Zeng LL, Shen H, Wang L, Li B, Liu L, Hu D. Fang P, et al. PLoS One. 2012;7(9):e45972. doi: 10.1371/journal.pone.0045972. Epub 2012 Sep 26. PLoS One. 2012. PMID: 23049910 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources